HIPEC for Colorectal Cancer With Peritoneal Carcinomatosis
This video reviews the use of hyperthermic intraperitoneal chemotherapy with cytoreductive surgery in colorectal cancer with peritoneal carcinomatosis.
Peritoneal carcinomatosis, present in about 10% to 15% of colorectal patients at the time of diagnosis, is difficult to detect by imaging and often only discovered intraoperatively.
In this video, Hans Schlitt, MD, of the University of Regensburg Medical Center in Germany, discusses the use of hyperthermic intraperitoneal chemotherapy (HIPEC) combined with cytoreductive surgery in this setting, which in selected patients is associated with improved survival.
Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Recent Videos
![“Everyone—patients, doctors—we all want the same thing. We want [patients] to live longer,” said Kiran Turaga, MD, MPH, on patients with peritoneal surface malignancies.](/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fcancernetwork%2F9b290688648a249e516474c175a3c06309426d15-2950x1568.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=30 "“Everyone—patients, doctors—we all want the same thing. We want [patients] to live longer,” said Kiran Turaga, MD, MPH, on patients with peritoneal surface malignancies.")
Related Content
